Document is current
Any future updates will be listed below
-
Authors
Cecchetti, Giordano https://orcid.org/0000-0002-6544-410X
Agosta, Federica https://orcid.org/0000-0003-3121-4979
Canu, Elisa https://orcid.org/0000-0001-5804-3378
Basaia, Silvia https://orcid.org/0000-0002-0722-6243
Barbieri, Alessandra
Cardamone, Rosalinda
Bernasconi, Maria Paola
Castelnovo, Veronica https://orcid.org/0000-0002-4125-9321
Cividini, Camilla https://orcid.org/0000-0003-0602-5375
Cursi, Marco https://orcid.org/0000-0002-7928-0417
Vabanesi, Marco https://orcid.org/0000-0002-8283-7079
Impellizzeri, Matteo https://orcid.org/0000-0002-8861-5303
Lazzarin, Serena Marita
Fanelli, Giovanna Franca
Minicucci, Fabio
Giacalone, Giacomo https://orcid.org/0000-0002-8834-4267
Falini, Andrea https://orcid.org/0000-0002-1461-8755
Falautano, Monica
Rovere-Querini, Patrizia https://orcid.org/0000-0003-2615-3649
Roveri, Luisa https://orcid.org/0000-0003-3114-4405
Filippi, Massimo https://orcid.org/0000-0002-5485-0479
- License Information
-
More Information
Article History
Received: 31 January 2022
Revised: 21 February 2022
Accepted: 22 February 2022
First Online: 6 March 2022
Declarations
:
: G. Cecchetti, S. Basaia, A. Barbieri, R. Cardamone, M.P. Bernasconi, V. Castelnovo, C. Cividini, M. Cursi, M. Vabanesi, M. Impellizzeri, S.M. Lazzarin, G.F. Fanelli, F. Minicucci, G. Giacalone, A. Falini, M. Falautano, P. Rovere-Querini, L. Roveri have nothing to disclose. E. Canu receives or has received research supports form the Italian Ministry of Health. F. Agosta is Associate Editor of NeuroImage: clinical, has received speaker honoraria from Roche and Biogen Idec, and receives or has received research supports from the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA), the European Research Council and Foundation Research on Alzheimer Disease. M. Filippi Editor-in-Chief of the Journal of Neurology and Associate Editor of Human Brain Mapping, Neurological Sciences, and Radiology; received compensation for consulting services and/or speaking activities from Almiral, Alexion, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries, and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Teva Pharmaceutical Industries, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).
: The study has been approved by the appropriate ethics committee and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All participants provided written informed consent prior to study inclusion.
Free to read: This content has been made available to all.
